Stereotactic body radiotherapy as primary treatment for elderly and medically inoperable patients with head and neck cancer
- 21 July 2020
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 42 (10) , 2880-2886
Abstract
Background Patients with head and neck cancer (HNC) who are not candidates for definitive treatment represent an increasing challenge, with limited data to guide management. Conventional local therapies such as surgery and chemoradiation can significantly impact quality of life (QoL). There has been limited data published using stereotactic body radiotherapy (SBRT) as primary treatment in previously unirradiated patients. We hypothesize that SBRT provides high rates of control while limiting toxicity. Methods A total of 66 medically unfit previously unirradiated patients with HNC were treated with SBRT, consisting of 35‐40 Gy to gross tumor volume and 30 Gy to clinical target volume in five fractions. Results Median age was 80 years. Local control (LC) and overall survival (OS) at 1 year were 73% and 64%. Two patients experienced grade 3 toxicity. Conclusion SBRT shows acceptable outcomes with relatively low toxicity in previously unirradiated patients with HNC who are medically unfit for conventional treatment. SBRT may provide an aggressive local therapy with high rates of LC and OS while maintaining QoL.Keywords
This publication has 47 references indexed in Scilit:
- Treatment of Older Patients With Head and Neck Cancer: A ReviewThe Oncologist, 2013
- Salvage Stereotactic Reirradiation With or Without Cetuximab for Locally Recurrent Head-and-Neck Cancer: A Feasibility StudyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung CancerJAMA, 2010
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patientsRadiotherapy and Oncology, 2009
- Hypofractionated radiotherapy denoted as the “Christie scheme”: An effective means of palliating patients with head and neck cancers not suitable for curative treatmentActa Oncologica, 2009
- Quad shot: A short but effective schedule for palliative radiation for head and neck carcinomaIndian Journal of Palliative Care, 2009
- The changing prevalence of comorbidity across the age spectrumCritical Reviews in Oncology/Hematology, 2008
- Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG AnalysisJournal of Clinical Oncology, 2008
- Predictive factors for complications in elderly patients who underwent head and neck oncologic surgeryHead & Neck, 2007
- Barriers to Clinical Trial Participation by Older Women With Breast CancerJournal of Clinical Oncology, 2003